4//SEC Filing
Kessler Paul D. 4
Accession 0001455244-11-000015
CIK 0000072444other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:13 PM ET
Size
8.9 KB
Accession
0001455244-11-000015
Insider Transaction Report
Form 4
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Transactions
- Sale
Common Stock
2011-04-05$5.76/sh−8,596$49,479→ 122,671 total - Award
Common Stock
2011-04-01+36,000→ 131,267 total - Award
Stock Option (right to buy)
2011-04-01+90,000→ 90,000 totalExercise: $5.81Exp: 2018-04-01→ Common Stock (90,000 underlying)
Footnotes (3)
- [F1]Restricted Stock which vests in four equal annual installments beginning on April 1, 2012.
- [F2]This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.
- [F3]This Option will become exercisable in four equal annual installments beginning on April 1, 2012.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001428524
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:13 PM ET
- Size
- 8.9 KB